Isocitrate Dehydrogenase 1 Inhibitor [EPC]

2178 reported adverse events

Drugs of this class: IVOSIDENIB VORASIDENIB

These side effects are most commonly reported by patients taking drugs of the Isocitrate Dehydrogenase 1 Inhibitor [EPC] class:

# Side effect Count
0 OFF LABEL USE 656
1 FATIGUE 171
2 NAUSEA 124
3 DIARRHOEA 123
4 DIFFERENTIATION SYNDROME 100
5 MALIGNANT NEOPLASM PROGRESSION 89
6 DISEASE PROGRESSION 88
7 PRODUCT USE ISSUE 88
8 FEBRILE NEUTROPENIA 87
9 DRUG INEFFECTIVE 83
See all common reactions for Isocitrate Dehydrogenase 1 Inhibitor [EPC]

Drugs of the Isocitrate Dehydrogenase 1 Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFERENTIATION SYNDROME 100 0.1362
1 CARBOHYDRATE ANTIGEN 19-9 INCREASED 8 0.0151
2 ACUTE MYELOID LEUKAEMIA RECURRENT 24 0.0112
3 BLAST CELL COUNT INCREASED 7 0.0067
4 PLATELET TRANSFUSION 8 0.0062
5 RED BLOOD CELL COUNT ABNORMAL 6 0.0041
6 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 7 0.0030
7 BONE MARROW TRANSPLANT 5 0.0026
8 GUILLAIN-BARRE SYNDROME 12 0.0025
9 ELECTROCARDIOGRAM QT PROLONGED 78 0.0022
See all enriched reactions for Isocitrate Dehydrogenase 1 Inhibitor [EPC]